BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8123836)

  • 1. Waldenstrom's macroglobulinemia.
    Dimopoulos MA; Alexanian R
    Blood; 1994 Mar; 83(6):1452-9. PubMed ID: 8123836
    [No Abstract]   [Full Text] [Related]  

  • 2. Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment.
    Rudnicki SA; Harik SI; Dhodapkar M; Barlogie B; Eidelberg D
    Neurology; 1998 Oct; 51(4):1210-3. PubMed ID: 9781565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasmapheresis in treatment of patients with Waldenström's macroglobulinemia.
    Lawson NS; Nosanchuk JS; Oberman HA; Meyers MC
    Transfusion; 1968; 8(3):174-8. PubMed ID: 4968993
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Gertz MA; Anagnostopoulos A; Anderson K; Branagan AR; Coleman M; Frankel SR; Giralt S; Levine T; Munshi N; Pestronk A; Rajkumar V; Treon SP
    Semin Oncol; 2003 Apr; 30(2):121-6. PubMed ID: 12720120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Waldenström's macroglobulinemia and cerebral lymphoplasmocytic proliferation: Bing and Neel syndrome. Apropos of a new case].
    Civit T; Coulbois S; Baylac F; Taillandier L; Auque J
    Neurochirurgie; 1997; 43(4):245-9. PubMed ID: 9686227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyneuropathy in Waldenström's macroglobulinemia. Deposition of M component on myelin sheaths.
    Julien J; Vital C; Vallat JM; Lagueny A; Deminiere C; Darriet D
    Arch Neurol; 1978 Jul; 35(7):423-5. PubMed ID: 208494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent lymphomas other than follicular and marginal zone lymphomas.
    Peinert S; Seymour JF
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):903-40, viii. PubMed ID: 18954743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waldenström's macroglobulinaemia: laboratory diagnosis and treatment.
    Owen RG; Johnson SA; Morgan GJ
    Hematol Oncol; 2000 Jun; 18(2):41-9. PubMed ID: 10960874
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.
    Kyle RA; Ansell SM; Kapoor P
    Best Pract Res Clin Haematol; 2016 Jun; 29(2):179-186. PubMed ID: 27825464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.
    Anderson KC; Alsina M; Bensinger W; Biermann JS; Cohen AD; Devine S; Djulbegovic B; Faber EA; Gasparetto C; Hernandez-Ilizaliturri F; Huff CA; Kassim A; Krishnan AY; Medeiros BC; Meredith R; Raje N; Schriber J; Singhal S; Somlo G; Stockerl-Goldstein K; Treon SP; Tricot G; Weber DM; Yahalom J; Yunus F; Kumar R; Shead DA;
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1211-9. PubMed ID: 23054875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 cryoglobulinemic neuropathy associated with lymphoplasmacytic lymphoma.
    Dang YL; Foster E; Finlay M; Evans A
    Acta Neurol Belg; 2021 Dec; 121(6):1887-1890. PubMed ID: 33104964
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peripheral neuropathy in Waldenstrom's macroglobulinemia. Antibody activity of monoclonal immunoglobulin M directed against vimentin].
    Dellagi K; Chedru F; Clauvel JP; Brouet JC
    Presse Med; 1984 May; 13(19):1199-201. PubMed ID: 6326084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deposits of paraprotein in small vessels as a cause of skin ulcers in Waldenström's macroglobulinemia.
    Wagner DR; Eckert F; Gresser U; Landthaler M; Middeke M; Zöllner N
    Clin Investig; 1993 Dec; 72(1):46-9. PubMed ID: 8136617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy associated with Waldenstrom's macroglobulinemia.
    Stoddard SR
    J Am Podiatr Med Assoc; 1994 Jan; 84(1):31-4. PubMed ID: 8295130
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of Waldenstrom's macroglobulinemia.
    McDermott MK; Bell EM
    Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossreacting idiotypes of kappa-monoclonal immunoglobulins M in sera of patients with Waldenström's macroglobulinemia.
    Wehmeier U; Rilke H; Patzold U; Schedel I; Deicher H
    Immunobiology; 1987 Dec; 176(1-2):144-53. PubMed ID: 2834288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum hyperviscosity in Waldenstrom's macroglobulinemia.
    Phatak DR
    Transfusion; 2003 Aug; 43(8):989. PubMed ID: 12869100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.